Vanguard Group
CO

Vanguard Group’s Global Cord Blood Corporation CO Stock Holding History

Vanguard Group’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,199,330
Closed -$6.93M – 4219
2019
Q2 		$6.93M Hold
1,199,330
– – ﹤0.01% 3055
2019
Q1 		$8.42M Buy
1,199,330
+9,339
+0.8% +$61.7K ﹤0.01% 2917
2018
Q4 		$7.67M Hold
1,189,991
– – ﹤0.01% 2894
2018
Q3 		$8.32M Buy
1,189,991
+6,190
+0.5% +$46.5K ﹤0.01% 3013
2018
Q2 		$11.2M Sell
1,183,801
-16,345
-1% -$157K ﹤0.01% 2847
2018
Q1 		$12.2M Buy
+1,200,146
New +$12.3M ﹤0.01% 2731

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Vanguard Group's CO Position: Q3 2019 in Review

Vanguard Group sold out of Global Cord Blood Corporation (CO) in Q3 2019, closing a stake of 1,199,330 shares — an estimated $6.93M sold.

Vanguard Group first reported a position in CO in Q1 2018 and held it in 6 quarters. The position peaked at $12.2M in Q1 2018. 44 funds tracked by Wall St. Rank hold CO as of Q3 2019.

  • Vanguard Group reported no remaining Global Cord Blood Corporation position as of Q3 2019 after selling out during the quarter.
  • Vanguard Group sold 1,199,330 Global Cord Blood Corporation shares in Q3 2019, an estimated $6.93M.
  • Vanguard Group first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 6 quarters.
  • Vanguard Group's Global Cord Blood Corporation position peaked at $12.2M in Q1 2018.
  • 44 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2019.

Based on Vanguard Group's 13F filing for Q3 2019, filed 14 Nov 2019.